Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS: NWBO · Delayed Price · USD
0.468
-0.004 (-0.87%)
Apr 24, 2024, 12:22 PM EDT - Market open

Northwest Biotherapeutics Market Cap

Northwest Biotherapeutics has a market cap or net worth of $556.91 million as of April 24, 2024. Its market cap has decreased by -4.05% in one year.

Market Cap
556.91M
Enterprise Value
605.22M
1-Year Change
-4.05%
Ranking
n/a
Category
Stock Price
$0.47

Market Cap Chart

Since December 31, 2001, Northwest Biotherapeutics's market cap has increased from $84.90M to $556.91M, an increase of 555.96%. That is a compound annual growth rate of 8.79%.

History

DateMarket Cap% Change
Apr 23, 2024561.70M-1.66%
Apr 22, 2024571.20M-
Apr 19, 2024571.20M-5.88%
Apr 18, 2024606.90M1.79%
Apr 17, 2024596.20M-0.78%
Apr 16, 2024600.90M0.59%
Apr 15, 2024597.40M-3.46%
Apr 12, 2024618.80M0.78%
Apr 11, 2024614.00M-0.39%
Apr 10, 2024616.40M-2.27%
Apr 9, 2024630.70M-1.30%
Apr 8, 2024639.00M-0.93%
Apr 5, 2024645.00M-0.54%
Apr 4, 2024648.50M-0.92%
Apr 3, 2024654.50M0.55%
Apr 2, 2024650.90M5.19%
Apr 1, 2024618.80M0.19%
Mar 28, 2024617.60M-13.50%
Mar 27, 2024714.00M12.99%
Mar 26, 2024631.90M3.51%
Mar 25, 2024610.50M6.21%
Mar 22, 2024574.80M-0.40%
Mar 21, 2024577.10M-0.62%
Mar 20, 2024580.70M-4.32%
Mar 19, 2024606.90M-1.73%
View and export this data all the way back to 2001. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 695.32B
Novo Nordisk 564.00B
UnitedHealth Group 452.88B
Johnson & Johnson 359.35B
Merck & Co. 321.49B
AbbVie 297.27B
AstraZeneca 217.39B
Thermo Fisher 209.32B
Market Cap Rankings